文献速递颈动脉与弓上血管

颈动脉血运重建术后围术期心肌损伤与一年心血管结局:TROPICAR研究随访

One Year Follow Up of the TROPonin In CArotid Revascularisation (TROPICAR) Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-01-08

TROPICAR前瞻性多中心队列纳入527例择期颈动脉内膜剥脱或支架患者,检测围术期高敏肌钙蛋白并随访一年。术后心肌损伤独立预测一年内心肌梗死(OR 6.54),心肌梗死无生存率显著降低(91.9% vs 98.2%)。

要点

  • 术后心肌损伤独立预测CEA/CAS后一年内心肌梗死(OR 6.54)。
  • 术后心肌损伤者一年心肌梗死无生存率显著低于无损伤者(91.9% vs 98.2%)。
  • 术前恶性肿瘤诊断亦独立预测一年内心肌梗死(OR 6.13)。

核心结论

  • 术后围术期心肌损伤独立预测颈动脉血运重建后一年内心肌梗死。
  • 术后心肌损伤患者为高风险亚组,应考虑针对性策略降低后续心脏不良事件风险。

研究设计与样本

  • 在五家三级中心入组,术前和术后检测高敏肌钙蛋白,随访一年。
  • 主要终点为心肌梗死,次要终点为卒中、心源性死亡和全因死亡。

主要发现

  • 一年随访完成505例(95.8%),以男性为主(n=349,69.1%),无症状者339/504例(67.3%),平均年龄71.6±8.6岁(范围41-90岁)。
  • 随访期间记录8例死亡,中心源性死亡1例(0.2%)。
  • 术后一年心肌梗死发生率为2.6%(n=13),卒中发生率为3.8%(n=19)。
  • 术后心肌损伤独立预测一年内心肌梗死(OR 6.54,95%CI 1.91-22.22,p=.003)。
  • 术前恶性肿瘤诊断独立预测一年内心肌梗死(OR 6.13,95%CI 1.67-22.73,p=.006)。

关键数值与推荐

  • 术后心肌损伤者一年心肌梗死无生存率为91.9%,无术后心肌损伤者为98.2%(log rank p=.003)。

临床怎么用

  • 颈动脉血运重建术后应关注围术期心肌损伤,将其作为一年心脏不良事件高风险标志。
  • 对术后心肌损伤患者可考虑针对性策略以降低后续心肌梗死风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to examine the association between peri-operative myocardial injury (MIn) and the occurrence of adverse cardiovascular events and or death one year after carotid revascularisation. METHODS: In this prospective, multicentre cohort study, 527 consecutive patients undergoing elective carotid endarterectomy (CEA) or carotid artery stenting (CAS) (June - October 2023) were enrolled across five tertiary centres. High sensitivity cardiac troponin was measured pre- and post-operatively, and patients were followed for one year. The primary endpoint was myocardial infarction (MI). Secondary endpoints were stroke, cardiac related death, and all cause death one year following CEA or CAS. Survival analysis was used to assess the impact of MIn on time dependent outcomes of interest. RESULTS: One year follow up was completed in 505 patients (95.8%), predominantly men (n = 349, 69.1%), asymptomatic (n = 339/504, 67.3%), with a mean age of 71.6 ± 8.6 years (range 41 - 90 years). During follow up, eight lethal outcomes were documented, of which one patient (0.2%) died due to cardiac related cause. One year post-operatively, the incidence of MI was 2.6% (n = 13) and the incidence of stroke was 3.8% (n = 19). Post-operative MIn and pre-operative diagnosis of malignancy independently predicted MI within one year after CEA or CAS (odds ratio [OR] 6.54, 95% confidence interval [CI] 1.91 - 22.22, p = .003; OR 6.13, 95% CI 1.67 - 22.73, p = .006, respectively). MI free survival was statistically significantly lower in patients with post-operative MIn one year after CEA or CAS (91.9% vs. 98.2%, log rank p = .003). CONCLUSION: Post-operative MIn independently predicted one year MI following CEA or CAS. Patients with post-operative MIn after carotid revascularisation represent a high risk subgroup in whom targeted strategies should be considered in order to reduce the risk of subsequent cardiac adverse events.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Jovanovic K, Jonsson M, Roy J, et al. One Year Follow Up of the TROPonin In CArotid Revascularisation (TROPICAR) Study. Eur J Vasc Endovasc Surg. 2026. PMID: 41519463. doi:10.1016/j.ejvs.2026.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。